T1	Intervention 0 29	Low-dose oral etoposide-based
T2	Intervention 164 182	low-dose etoposide
T3	Intervention 338 383	epipodophyllotoxins during frontline therapy.
T4	Intervention 434 541	patients received etoposide (50 mg/m(2) per day) administered orally as a single agent once or twice daily.
T5	Intervention 580 627	dexamethasone, vincristine, and L-asparaginase.
T6	Intervention 628 668	Etoposide was administered until Day 22.
T7	Intervention 669 787	Two courses of consolidation therapy were followed by continuation therapy or hematopoietic stem cell transplantation.
T8	Intervention 1230 1248	low-dose etoposide
